Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research

BTDMJB. 2010; 6(4): 137-141


Botulinum toxin type A application in dystonia

Murat Çabalar, Vildan Yayla, Tülay Yetkin.

Abstract
Objective: Botulinum toxin (BTX) causes muscle paralysis by blocking acetylcholine secretion at the neuromuscular junctions. In this study, results of BTX applications in our neurology department were described. Analysis of dystonia patients and the duration of BTX efficacy were investigated.
Material and Methods: Fiftyseven dystonia patients, who admitted to our outpatient clinics between July 2007-August 2009, were injected by Botulinum type A. In this treatment, dental injector for the neck and extremity muscles, insulin injectors for the facial muscles were used. Statistically, Student t-test was applied. Results were considered significant at the level of p0,05).
Conclusion: Botulinum A toxin treatment is safe and effective for all dystonia types, especially HFS and BFS.

Key words: Movement disorders, dystonia, Botulinum toxin A



Article Language: Turkish English



Share this Article


Advertisement
Journal of Apitherapy

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.